Fig. 3

Patient outcomes of luminal IDC and luminal ILC stratified according to lymph node status; (a) disease free survival in lymph node-negative patients (b) disease free survival in lymph node-positive patients (c) overall survival in lymph node-positive patients, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma